356 related articles for article (PubMed ID: 10875609)
1. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
De Luca A; Giancola ML; Cingolani A; Ammassari A; Murri R; Antinori A
AIDS Res Hum Retroviruses; 2000 Jun; 16(9):835-43. PubMed ID: 10875609
[TBL] [Abstract][Full Text] [Related]
2. Sustained suppression of plasma HIV RNA is associated with an increase in the production of mitogen-induced MIP-1alpha and MIP-1beta.
Kumar D; Parato K; Kumar A; Sun E; Cameron DW; Angel JB
AIDS Res Hum Retroviruses; 1999 Aug; 15(12):1073-7. PubMed ID: 10461827
[TBL] [Abstract][Full Text] [Related]
3. Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir.
Bisset LR; Rothen M; Joller-Jemelka HI; Dubs RW; Grob PJ; Opravil M
AIDS; 1997 Mar; 11(4):485-91. PubMed ID: 9084796
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of circulating beta-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals.
Kakkanaiah VN; Ojo-Amaize EA; Peter JB
Clin Diagn Lab Immunol; 1998 Jul; 5(4):499-502. PubMed ID: 9665956
[TBL] [Abstract][Full Text] [Related]
5. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment.
Ye P; Kazanjian P; Kunkel SL; Kirschner DE
J Lab Clin Med; 2004 May; 143(5):310-9. PubMed ID: 15122175
[TBL] [Abstract][Full Text] [Related]
6. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
Montes de Oca Arjona M; Pérez Cano R; Orozco MJ; Martín Aspas A; Guerrero F; Fernández Gutiérrez Del Alamo C; Girón-González JA
Clin Microbiol Infect; 2005 Jan; 11(1):57-62. PubMed ID: 15649305
[TBL] [Abstract][Full Text] [Related]
7. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression.
Llano A; Barretina J; Gutiérrez A; Clotet B; Esté JA
J Virol; 2003 Apr; 77(7):4389-95. PubMed ID: 12634395
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
[TBL] [Abstract][Full Text] [Related]
10. Chemokine mRNA levels in mononucleated cells of HIV-infected patients before and after initiation of PI- versus NNRTI-containing HAART.
Wasmuth JC; Nischalke HD; Jütte A; Fätkenheuer G; Salzberger B; Sauerbruch T; Spengler U; Rockstroh JK; Dumoulin FL
Antiviral Res; 2004 Mar; 61(3):207-12. PubMed ID: 15168802
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals.
Lewis MJ; Gautier VW; Wang XP; Kaplan MH; Hall WW
J Immunol; 2000 Oct; 165(7):4127-32. PubMed ID: 11034425
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific production of RANTES, macrophage inflammatory protein (MIP)-1alpha, and MIP-1beta in vitro is a correlate of reduced human immunodeficiency virus burden in vivo.
Ferbas J; Giorgi JV; Amini S; Grovit-Ferbas K; Wiley DJ; Detels R; Plaeger S
J Infect Dis; 2000 Oct; 182(4):1247-50. PubMed ID: 10979927
[TBL] [Abstract][Full Text] [Related]
13. Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells.
Staruch MJ; Camacho R; Dumont FJ
Cell Immunol; 1998 Dec; 190(2):121-31. PubMed ID: 9878113
[TBL] [Abstract][Full Text] [Related]
14. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
Saha K; Bentsman G; Chess L; Volsky DJ
J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304
[TBL] [Abstract][Full Text] [Related]
15. Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infection.
Burton CT; Hardy GA; Sullivan AK; Nelson MR; Gazzard B; Gotch FM; Imami N
Clin Exp Immunol; 2002 Nov; 130(2):286-92. PubMed ID: 12390317
[TBL] [Abstract][Full Text] [Related]
16. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
[TBL] [Abstract][Full Text] [Related]
17. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L
AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection.
Carter LM; Peters BS; Ellis BA; Wolstencroft RA
J Infect; 2000 Nov; 41(3):252-5. PubMed ID: 11120614
[TBL] [Abstract][Full Text] [Related]
19. Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy.
Blanco J; Cabrera C; Jou A; Ruiz L; Clotet B; Esté JA
AIDS; 1999 Apr; 13(5):547-55. PubMed ID: 10203379
[TBL] [Abstract][Full Text] [Related]
20. Activation of beta-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis.
Mayanja-Kizza H; Wajja A; Wu M; Peters P; Nalugwa G; Mubiru F; Aung H; Vanham G; Hirsch C; Whalen C; Ellner J; Toossi Z
J Infect Dis; 2001 Jun; 183(12):1801-4. PubMed ID: 11372034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
